Lantern Pharma Announces Completion of Type C Meeting with FDA, Providing Clarity on Regulatory Pathway for Pediatric CNS Cancer Trial
LTPH(LTPH) DALLAS--(BUSINESS WIRE)--Type C Meeting for LP-184/STAR-001
September 3, 2025Clinical Trials
Read more →